Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Participants With Schizophrenia
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03593213. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Placebo-Controlled, Randomized Withdrawal, Multicenter Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Patients With Schizophrenia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
1. To evaluate the efficacy and safety of cariprazine at a target dose of 4.5 milligram per day (mg/d) compared with placebo in prevention of relapse in patients with schizophrenia 2. To evaluate the efficacy and safety of cariprazine at a target dose of 3.0 mg/d compared with placebo in prevention of relapse in patients with schizophrenia who were initially stabilized on a target dose of 4.5 mg/d
Study identification
- NCT ID
- NCT03593213
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 587 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 64 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 30, 2018 (Actual)
- Primary completion
- Feb 11, 2021 (Actual)
- Completion
- Feb 11, 2021 (Actual)
- Last update posted
- Apr 11, 2022
2018 – 2021
United States locations
- U.S. sites
- 42
- U.S. states
- 14
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pillar Clinical Research | Bentonville | Arkansas | 72712 | — |
| Woodland International Research Group | Little Rock | Arkansas | 72211 | — |
| Woodland Research Northwest, LLC | Rogers | Arkansas | 72758 | — |
| Advanced Research Center, Inc. | Anaheim | California | 92805 | — |
| CITrials - Bellflower | Bellflower | California | 90706 | — |
| Synexus Clinical Research US, Inc. | Cerritos | California | 90703 | — |
| ATP Clinical Research, Inc. | Costa Mesa | California | 92626 | — |
| California Pharmaceutical Research Institute, Inc. | Costa Mesa | California | 92626 | — |
| ProScience Research Group | Culver City | California | 90230 | — |
| Collaborative Neuroscience Research Network, LLC. | Garden Grove | California | 92845 | — |
| Behavioral Research Specialists, LLC | Glendale | California | 91206 | — |
| Omega Clinical Trials | La Habra | California | 90631 | — |
| Synergy San Diego | Lemon Grove | California | 91945 | — |
| Alliance Research | Long Beach | California | 90807 | — |
| Excell Research, Inc | Oceanside | California | 92056 | — |
| Orange County Neuropsychiatric Research Center, LLC | Orange | California | 92868 | — |
| CNRI-Los Angeles | Pico Rivera | California | 90660 | — |
| University of California San Diego | San Diego | California | 92103-8229 | — |
| Schuster Medical Research Institute | Sherman Oaks | California | 91423 | — |
| Collaborative Neuroscience Research, LLC | Torrance | California | 90502 | — |
| Wilks & Safirstein MD PA D/B/A MD Clinical | Hallandale | Florida | 33009 | — |
| Southern Winds Hospital | Hialeah | Florida | 33012 | — |
| Research Centers of America | Hollywood | Florida | 33024 | — |
| Synexus Clinical Research, Inc | Atlanta | Georgia | 30328 | — |
| Atlanta Center for Medical Research | Atlanta | Georgia | 30331 | — |
| iResearch Atlanta LLC | Decatur | Georgia | 30030 | — |
| Atlanta Behavioral Research, LLC | Dunwoody | Georgia | 30338 | — |
| AMITA Health Alexian Brothers Center for Psychiatric Research | Hoffman Estates | Illinois | 60169 | — |
| Louisiana Clinical Research | Shreveport | Louisiana | 71101 | — |
| CBH Health LLC | Gaithersburg | Maryland | 20877 | — |
| Altea Research | Las Vegas | Nevada | 85012 | — |
| Alea Research Institute | Las Vegas | Nevada | 89102 | — |
| Hassman Research Institute | Berlin | New Jersey | 08009 | — |
| Neurobehavioral Research, Inc. | Cedarhurst | New York | 11516 | — |
| New Hope Clinical Research | Charlotte | North Carolina | 28211 | — |
| Clinical Inquest Center Ltd. | Beavercreek | Ohio | 45431 | — |
| OSY Psychiatry Department | Columbus | Ohio | 43210 | — |
| Professional Psychiatric Services | Mason | Ohio | 45069 | — |
| Sooner Clinical Research | Oklahoma City | Oklahoma | 23112 | — |
| Community Clinical Research, Inc. | Austin | Texas | 78754 | — |
| Pillar Clinical Research | Richardson | Texas | 75042 | — |
| Pillar Healthcare | Richardson | Texas | 75080 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 55 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03593213, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 11, 2022 · Synced Nov 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.